SUPN · CIK 0001356576 · operating
SUPERNUS PHARMACEUTICALS, INC. (SUPN) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $3.2 billion, SUPERNUS PHARMACEUTICALS, INC. is a mid-cap company. The stock currently trades at $55.09, up 0.66% today, with a 52-week range of $29.16–$59.68. The company trades at a forward P/E of 13.1x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-0.68 | $-0.68 | -151.5% | |
| 2024 | $1.32 | $1.34 | +26.9% | |
| 2022 | $1.04 | $1.13 | +6.1% | |
| 2021 | $0.98 | $1.01 | -58.5% | |
| 2020 | $2.36 | $2.41 | +280.6% | |
| 2019 | $0.62 | $0.63 | +29.2% | |
| 2018 | $0.48 | $0.50 | +84.6% | |
| 2017 | $0.26 | $0.27 | +0.0% | |
| 2016 | $0.26 | $0.29 | +85.7% | |
| 2015 | $0.14 | $0.14 | +40.0% | |
| 2014 | $0.10 | $0.10 | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-03-02 | 0001356576-26-000011 | SEC ↗ |
| 2024-12-31 | 2025-02-25 | 0001356576-25-000017 | SEC ↗ |
| 2023-12-31 | 2024-02-27 | 0001356576-24-000013 | SEC ↗ |
| 2022-12-31 | 2023-03-09 | 0001356576-23-000016 | SEC ↗ |
| 2021-12-31 | 2022-04-13 | 0001356576-22-000025 | SEC ↗ |
| 2020-12-31 | 2021-03-08 | 0001356576-21-000028 | SEC ↗ |
| 2019-12-31 | 2020-02-28 | 0001356576-20-000010 | SEC ↗ |
| 2018-12-31 | 2019-03-01 | 0001047469-19-000828 | SEC ↗ |
| 2017-12-31 | 2018-03-01 | 0001047469-18-001210 | SEC ↗ |
| 2016-12-31 | 2017-03-16 | 0001047469-17-001684 | SEC ↗ |
| 2015-12-31 | 2016-03-09 | 0001047469-16-010884 | SEC ↗ |
| 2014-12-31 | 2015-03-12 | 0001047469-15-002068 | SEC ↗ |
| 2013-12-31 | 2014-03-21 | 0001047469-14-002791 | SEC ↗ |